ResearcherNational Institute for Health and Care ResearchActive in the last 2 years
Guruprasad Padur Aithal
Matched on ORCID iD 0000-0003-3924-4830; OpenAlex author ID A5084012349. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper, 1 trial
Papers 3
- Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreat… Co-author DOI 10.1016/j.ejca.2026.116592↗
- Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer. Co-author DOI 10.1038/s41395-018-0395-y↗
- Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the intr… Co-author DOI 10.1097/mpa.0000000000000246↗
Trials 1
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paula Ghaneh · 3 shared papers, 2015–2026 · strength 0.33
- Paper Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the … DOI 10.1016/j.ejca.2026.116592↗
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Paper Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pan… DOI 10.1097/mpa.0000000000000246↗
- William Greenhalf · 3 shared papers, 2015–2026 · strength 0.33
- Paper Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the … DOI 10.1016/j.ejca.2026.116592↗
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Paper Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pan… DOI 10.1097/mpa.0000000000000246↗
- Christopher Michael Halloran · 3 shared papers, 2015–2026 · strength 0.33
- Paper Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the … DOI 10.1016/j.ejca.2026.116592↗
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Paper Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pan… DOI 10.1097/mpa.0000000000000246↗
- Andrew Malvern Smith · 2 shared papers, 2019–2026 · strength 0.29
- Paper Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the … DOI 10.1016/j.ejca.2026.116592↗
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Zaed Z. R. Hamady · 2 shared papers, 2019–2026 · strength 0.29
- Paper Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the … DOI 10.1016/j.ejca.2026.116592↗
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Stephen P. Pereira · 2 shared papers, 2019–2026 · strength 0.29
- Paper Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the … DOI 10.1016/j.ejca.2026.116592↗
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Eithne Costello · 2 shared papers, 2019–2026 · strength 0.29
- Paper Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the … DOI 10.1016/j.ejca.2026.116592↗
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Annabelle Boughey · 1 shared paper, 2026 · strength 0.22
- Mark Taylor · 1 shared paper, 2026 · strength 0.22
- Kofi W. Oppong · 1 shared paper, 2026 · strength 0.22
- Tejinderjit Athwal · 1 shared paper, 2026 · strength 0.22
- Phillip J. Hopley · 1 shared paper, 2026 · strength 0.22
- Christopher Grocock · 2 shared papers, 2015–2019 · strength 0.11
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Paper Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pan… DOI 10.1097/mpa.0000000000000246↗
- Thomas Hanna · 2 shared papers, 2015–2019 · strength 0.11
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Paper Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pan… DOI 10.1097/mpa.0000000000000246↗
- James Nicholson · 2 shared papers, 2015–2019 · strength 0.11
- Paper Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated … DOI 10.1038/s41395-018-0395-y↗
- Paper Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pan… DOI 10.1097/mpa.0000000000000246↗
- Andrea Sheel · 1 shared paper, 2019 · strength 0.07
- Colin J. McKay · 1 shared paper, 2019 · strength 0.07
- Jayapal Ramesh · 1 shared paper, 2019 · strength 0.07
- Markus M. Lerch · 1 shared paper, 2019 · strength 0.07
- Pascal R. Hammel · 1 shared paper, 2019 · strength 0.07
- Martin G. Lombard · 1 shared paper, 2015 · strength 0.04
- John P. Neoptolemos · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.